Imetit and N-methyl derivatives. The transition from potent agonist to antagonist at histamine H3 receptors.1
- 31 October 1992
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 2 (10) , 1231-1234
- https://doi.org/10.1016/s0960-894x(00)80219-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Two novel, potent and selective histamine H3 receptor agonistsBioorganic & Medicinal Chemistry Letters, 1992
- Histaminergic Agonists and Antagonists Recent DevelopmentsPublished by Elsevier ,1991
- Histaminergic transmission in the mammalian brainPhysiological Reviews, 1991
- Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonistsJournal of Medicinal Chemistry, 1988
- Highly potent and selective ligands for histamine H3-receptorsNature, 1987
- Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptorNature, 1983
- 1980 Award in medicinal chemistry. Medicinal chemistry and dynamic structure-activity analysis in the discovery of drugs acting at histamine H2 receptorsJournal of Medicinal Chemistry, 1981
- Definition and Antagonism of Histamine H2-receptorsNature, 1972
- RECEPTORS MEDIATING SOME ACTIONS OF HISTAMINEBritish Journal of Pharmacology and Chemotherapy, 1966
- 1046. Salts of amidines and related compounds. Part II. An X-ray crystallographic study of S-methylthiouronium p-chlorobenzoate: the constancy of the amidinium carboxylate grouping and its importance for protein conformationsJournal of the Chemical Society, 1963